Neurodegenerative Diseases

Original Paper

Aberrant Connectivity in Mild Cognitive Impairment and Alzheimer Disease Revealed by Multimodal Neuroimaging Data

Li Q.a · Wu X.a, b · Xie F.a · Chen K.c · Yao L.a, b · Zhang J.a · Guo X.a · Li R.d · and Alzheimer's Disease Neuroimaging Initiative

Author affiliations

aCollege of Information Science and Technology, and bState Key Laboratory of Cognitive Neuroscience and Learning, Beijing Normal University, Beijing, China; cBanner Alzheimer's Institute and Banner Good Samaritan PET Center, Phoenix, AZ, USA; dCenter on Aging Psychology, CAS Key Laboratory of Mental Health, Institute of Psychology, Beijing, China

Related Articles for ""

Neurodegener Dis 2018;18:5–18

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 26, 2017
Accepted: October 16, 2017
Published online: January 13, 2018
Issue release date: March 2018

Number of Print Pages: 14
Number of Figures: 5
Number of Tables: 5

ISSN: 1660-2854 (Print)
eISSN: 1660-2862 (Online)

For additional information: https://www.karger.com/NDD

Abstract

Background: Making use of multimodal data simultaneously to understand the neural mechanism of mild cognitive impairment (MCI) has been in the focus nowadays. The simultaneous use of multimodal data can take advantage of each modality which may only provide the view of one specific aspect of the brain. Objective: To this end, the present study used structural magnetic resonance imaging (sMRI), fluorodeoxyglucose positron emission tomography (FDG-PET) and florbetapir PET to reveal the integrated brain network between MCI and normal controls (NCs). Methods: In this study, 116 MCI, 116 NC and 116 Alzheimer disease (AD) subjects from the Alzheimer's Disease Neuroimaging Initiative were included for the evaluation of the brain covariance graphic model. Sparse inverse covariance estimation was utilized to get the graphic model. Results: The connections among different brain regions were quite different between NC and MCI or between MCI and AD subjects (p < 0.01). The number of connections, which were represented by the covariance among different brain regions in the graphic model, decreased from NC to MCI and then AD, especially in the temporal lobe, occipital-parietal lobe and parietal-temporal lobe. Conclusion: These findings are good evidence to reveal the difference between MCI or AD and NC, and enhance the understanding of MCI.

© 2018 S. Karger AG, Basel




Related Articles:


References

  1. Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, DeKosky ST: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133-1142.
  2. Garcés P, Pineda-Pardo JA, Canuet L, Aurtenetxe S, Lopez ME, Marcos A, et al: The default mode network is functionally and structurally disrupted in amnestic mild cognitive impairment - a bimodal MEG-DTI study. Neruoimage Clin 2014;6:214-221.
  3. Wee CY, Yap PT, Li W, Denny K, Browndyke JN, Potter GG, et al: Enriched white matter connectivity networks for accurate identification of MCI patients. Neuroimage 2011;54:1812-1822.
  4. Zhou L, Wang Y, Li Y, Yap PT, Shen D; Alzheimer's Disease Neuroimaging Initiative (ADNI): Hierarchical anatomical brain networks for MCI prediction: revisiting volumetric measures. PLoS One 2011;6:e21935.
  5. Lenzi D, Serra L, Perri R, Pantano P, Lenzi GL, Paulesu E, et al: Single domain amnestic MCI: a multiple cognitive domains fMRI investigation. Neurobiol Aging 2011;32:1542-1557.
  6. Suk HI, Wee CY, Shen D: Discriminative group sparse representation for mild cognitive impairment classification. Machine learning in medical imaging. Lect Notes Comput Sci 2013;8184:131-138.
  7. Nobili F, Mazzei D, Dessi B, Morbelli S, Brugnolo A, Barbieri P, et al: Unawareness of memory deficit in amnestic MCI: FDG-PET findings. J Alzheimer Dis 2010;22:993-1003.
  8. Zhang S, Smailagic N, Hyde C, Noel-Storr AH, Takwoingi Y, McShane R, et al: C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev 2014;7:15-17.
  9. Camus V, Payoux P, Barré L, Desgranges B, Voisin T, Tauber C, et al: Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment. Eur J Nucl Med Mol Imag 2012;39:621-631.
  10. Saint-Aubert L, Barbeau EJ, Péran P, Nemmi F, Vervueren C, Mirabel H, et al: Cortical florbetapir-PET amyloid load in prodromal Alzheimer's disease patients. EJNMMI Res 2013;3:1-9.
  11. Pengas G, Hodges J, Watson P, Nestor P: Focal posterior cingulate atrophy in incipient Alzheimer's disease. Neurobiol Aging 2010;31:25-33.
  12. Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehricy S, Habert MO, et al: Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database. Neuroimage 2010;56:766-781.
  13. Martino ME, Villoria JG, Lacalle-Aurioles M, Olazaran J, Cruz I, Navarro E: Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls. Ann Nucl Med. 2013;27:600-609.
  14. Sanabria-Diaz G, Martinez-Montes E, Melie-Garcia L: Glucose metabolism during resting state reveals abnormal brain networks organization in Alzheimer's disease and mild cognitive impairment. PLos One 2013;8:e68860.
  15. Teipel SJ, Kurth J, Krause B, Grothe MJ: The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - beyond classical regression. Clin Neuroimage 2014;4:244-247.
  16. Calhoun VD, Adali T, Kiehl KA, Astur R, Pekar JJ, Pearlson GD: A method for multitask fMRI data fusion applied to schizophrenia. Hum Brain Mapp 2006;27:598-610.
  17. McCarley RW, Nakamura M, Shenton ME, Salisbury DF: Combining ERP and structural MRI information in first episode schizophrenia and bipolar disorder. Clin EEG Neurosci 2008;39:57-60.
  18. Michael AM, Baum SA, White T, Demirci O, Andreasen NC, Segall JM, et al: Does function follow form? Methods to fuse structural and functional brain images show decreased linkage in schizophrenia. Neuroimage 2010;49:2626-2637.
  19. Sui J, Pearlson G, Caprihan A, Adali T, Kiehl KA, Liu J, et al: Discriminating schizophrenia and bipolar disorder by fusing fMRI and DTI in a multimodal CCAC joint ICA model. Neuroimage 2011;57:839-855.
  20. Sui J, He H, Yu Q, Chen J, Rogers J, Pearlson G, et al: Combination of resting state fMRI, DTI, and sMRI data to discriminate schizophrenia by N-way MCCA + jICA. Front Hum Neurosci 2013;7:235.
  21. Cui Y, Liu B, Luo S, Zhen X, Fan M, Liu T, et al; Alzheimer's Disease Neuroimaging Initiative: Identification of conversion from mild cognitive impairment to Alzheimer's disease using multivariate predictors. PLoS One 2011;6:e21896.
  22. Hinrichs C, Singh V, Xu G, Johnson SC: Predictive markers for AD in a multi-modality framework: an analysis of MCI progression in the ADNI population. Neuroimage 2011;55:574-589.
  23. Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, et al: Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging 2010;31:1429-1442.
  24. Westman E, Muehlboeck JS, Simmons A: Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage 2012;62:229-238.
  25. Yuan L, Wang Y, Thompson PM, Narayan VA, Ye J: Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data. Neuroimage 2012;61:622-632.
  26. Zhang D, Wang Y, Zhou L Yuan H, Shen D; Alzheimer's Disease Neuroimaging Initiative: Multimodal classification of Alzheimer's disease and mild cognitive impairment. Neuroimage 2011;55:856-867.
  27. Son SJ, Kim J, Seo J, Lee J, Park H: Connectivity analysis of normal and mild cognitive impairment patients based on FDG and PiB-PET images. Neurosci Res 2015;98:50-58.
  28. Zhang D, Shen D: Predicting future clinical changes of MCI patients using longitudinal and multimodal biomarkers. PLoS One 2012;7:e33182.
  29. Suk HI, Lee SW, Shen DG: Latent feature representation with stacked auto-encoder for AD/MCI diagnosis. Brain Struct Funct 2015;220:841-859.
  30. Shi YH, Suk HI, Gao Y, Shen DG: Joint coupled-feature representation and coupled boosting for AD diagnosis. Proc IEEE Comput Soc Conf Comput Vis Pattern Recognit 2014;2014:2721-2728.
  31. Shaffer JL, Petrella JR, Shelon FC, et al: Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers. Radiology 2013;266:583-591.
  32. Banerjee O, El Ghaoui L, d'Aspremont A: Model selection through sparse maximum likelihood estimation for multivariate Gaussian or binary data. J Machine Learning Res 2008;9:485-516.
  33. Berge A, Jensen AC, Solberg AHS: Sparse inverse covariance estimates for hyperspectral image classification. Geoscience and remote sensing. IEEE Trans Geosci Remote Sens 2007;45:1399-1407.
  34. Bilmes JA: Factored sparse inverse covariance matrices. Proc IEEE Int Conf Acoust Speech Signal Processing, Istanbul, 2000, No 1002, pp 1009-1012.
  35. Dobra A, Hans C, Jones B, Nevins JR, Yao G, West M: Sparse graphical models for exploring gene expression data. J Multivar Anal 2004;90:196-212.
    External Resources
  36. Li H, Gui J: Gradient directed regularization for sparse Gaussian concentration graphs, with applications to inference of genetic networks. Biostatistics 2006;7:302-317.
  37. Huang S, Li J, Sun L, Liu J, Wu T, Chen K, et al: Learning brain connectivity of Alzheimer's disease from neuroimaging data. Adv Neural Inf Process Syst 2009;22:808-816.
  38. Sun L, Patel R, Liu J, Chen K, Wu T, Li J, et al: Mining brain region connectivity for Alzheimer's disease study via sparse inverse covariance estimation. Proc ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, Paris, 2009, pp 1335-1344.
  39. Folstein MF, Folstein SE, McHugh PR: “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
  40. Morris JC: The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
  41. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-939.
  42. Rajapakse JC, Giedd JN, Rapoport JL: Statistical approach to segmentation of single-channel cerebral MR images. IEEE Trans Med Imag 1997;16:176-186.
  43. Tohka J, Zijdenbos A, Evans A: Fast and robust parameter estimation for statistical partial volume models in brain MRI. Neuroimage 2004;23:84-97.
  44. Manjón JV, Coupé P, Martí-Bonmatí L, Collins DL, Robles M: Adaptive non-local means denoising of MR images with spatially varying noise levels. J Magn Reson Imag 2010;31:192-203.
  45. Ashburner J: A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95-113.
  46. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al: Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002;15:273-289.
  47. Donoho DL: For most large underdetermined systems of linear equations, the minimal L1-norm solution is also the sparsest solution. Commun Pure Appl Math 2006;59:797-829.
  48. Tibshirani R: Regression shrinkage and selection via the lasso. J R Stat Soc Ser B Methodol 1996;58:267-288.
  49. Friedman J, Hastie T, Tibshirani R: Sparse inverse covariance estimation with the graphical lasso. Biostatistics 2008;9:432-441.
  50. lafferty J: Model selection through sparse maximum likelihood estimation for multivariate Gaussian or binary data. J Machine Learn Res 2008;9:485-516.
  51. Dickerson BC, Salat DH, Bates JF, Monika Atiya MD, Killiany RJ, Greve DN, et al: Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004;56:27-35.
  52. Ferreira D, Cavallin L, Larsson EM, Muehlboeck JS, Mecocci P, Vellas B, et al: Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment. J Intern Med 2015;278:277-290.
  53. Hua X, Leow AD, Parikshak N, Lee S, Chiang MC, Toga AW, et al; Alzheimer's Disease Neuroimaging Initiative: Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage 2008;43:458-469.
  54. Jiang X, Zhu D, Li K, Zhang T, Wang L, Shen D, et al: Predictive models of resting state networks for assessment of altered functional connectivity in mild cognitive impairment. Brain Imag Behav 2014;8:542-557.
  55. Jokinen H, Lipsanen J, Schmidt R, Fazekas F, Gouw AA, van der Flier WM, et al: Brain atrophy accelerates cognitive decline in cerebral small vessel disease. The LADIS Study. Neurology 2012;78:1785-1792.
  56. Ruschel M, Knosche TR, Friederici AD, Turner R, Geyer S, Anwander A: Connectivity architecture and subdivision of the human inferior parietal cortex revealed by diffusion MRI. Cereb Cortex 2014;24:2436-2448.
  57. Huang S, Li J, Ye J, Fleisher A, Chen K, Wu T, et al: Brain effective connectivity modeling for Alzheimer's disease by sparse Gaussian Bayesian network. KDD 2011;931-939.
  58. Supekar K, Menon V, Rubin D, Musen M, Greicius MD: Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS Comput Biol 2008;4:e1000100.
  59. Gong G, He Y, Concha L, Lebel C, Gross DW, Evans AC, et al: Mapping anatomical connectivity patterns of human cerebral cortex using in vivo diffusion tensor imaging tractography. Cereb Cortex 2009;19:524-536.
  60. Hagmann P, Cammoun L, Gigandet X, Meuli R, Honey CJ, Wedeen VJ, et al: Mapping the structural core of human cerebral cortex. PLoS Biol 2008;6:e159.
  61. Ye BS, Seo SW, Kim GH, Noh Y, Cho H, Yoon CW, et al: Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients. Alzheimers Dement 2015;11:494-503.
  62. Brickman AM, Zahodne LB, Guzman VA, et al: Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence. Neurobiol Aging 2015;36:27-32.
  63. Buckner RL, Sepulcre J, Talukdar T, Krienen FM, Liu H, Hedden T, et al: Cortical hubs revealed by intrinsic functional connectivity: mapping, assessment of stability, and relation to Alzheimer's disease. J Neurosci 2009;29:1860-1873.
  64. Sepulcre J, Liu H, Talukdar T, Martincorena I, Yeo BT, Buckner RL: The organization of local and distant functional connectivity in the human brain. PLoS Comput Biol 2010;6:e1000808.
  65. Smith CD: Neuroimaging through the course of Alzheimer's disease. J Alzheimers Dis 2010;19:273-290.
  66. Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L: Mild cognitive impairment: a concept in evolution. J Intern Med 2014;275:214-228.
  67. Caroli A, Geroldi C, Nobili F, Barnden LR, Guerra UP, Bonetti M, et al: Functional compensation in incipient Alzheimer's disease. Neurobiol Aging 2010;31:387-397.
  68. Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, et al: Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age. JAMA Neurol 2015;72:1029-1042.
  69. Xu L, Wu X, Chen K, Yao L: Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment. Comput Methods Programs Biomed 2015;122:182-190.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 26, 2017
Accepted: October 16, 2017
Published online: January 13, 2018
Issue release date: March 2018

Number of Print Pages: 14
Number of Figures: 5
Number of Tables: 5

ISSN: 1660-2854 (Print)
eISSN: 1660-2862 (Online)

For additional information: https://www.karger.com/NDD


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP